BN-006

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBN-006
Drug Alias NameTNF antagonist (Bone Medical)anti-TNF therapy (Bone Medical)BN-006
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-6 inhibitorsTumor necrosis factor inhibitors
TargetsInterleukin-6Tumor necrosis factor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBotanix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBotanix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A